Profilo
James S.
Sigler has been a Director of ViaCell, Inc. since July 2005.
He served as Vice President of Manufacturing for RenaMed Biologics, Inc. from March 2006 to March 2007.
Prior to joining RenaMed, Mr. Sigler was Vice President of Operations and Clinical Supply for Acceleron Pharma, Inc. from August 2004 to March 2006.
He was Vice President of Manufacturing and Development and Vice President of Manufacturing for Curis, Inc. from 1998 to December 2002.
Previously, he was a Divisional Head of Manufacturing at Genzyme Corporation.
He served for 5 years in the U.S.
Navy, serving as a Nuclear Propulsion-Trained Officer on Board USS Enterprise.
Mr. Sigler received a BS from Cornell University and an MBA from Harvard Business School.
Precedenti posizioni note di James S. Sigler
| Società | Posizione | Fine |
|---|---|---|
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 16/11/2007 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- James S. Sigler
